In a report released on March 5, Seiji Wakao from J.P. Morgan maintained a Hold rating on Astellas Pharma (ALPMF – Research Report), with a price target of Yen1,700.00. The company’s shares ...

Astellas signed a memorandum of agreement with Yaskawa in May 2024. Credit: yu_photo/Shutterstock. Astellas Pharma and the Yaskawa Electric Corporation have agreed to form a joint venture (JV) that ...

(RTTNews) - Japan's Astellas Pharma Inc. (ALPMY, ALPMY) announced that it has signed a definitive agreement with YASKAWA Electric Corp. to establish a joint venture for the development of a cell ...

Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance accuracy, reproducibility, and efficiency in cell manufacturing. Astellas ...

Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders.

NORTHBROOK, Ill., Feb. 27, 2025 /PRNewswire/ -- Astellas Pharma U.S. Inc. (Head of Commercial: Mike Petroutsas, "Astellas"), and MBC BioLabs, a premier launchpad for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GOOD MORNING JEN AND RHONDELLA RED BULL HEAVY METAL IS MAKING ITS BOSTON DEBUT THIS WEEKEND WITH SOME OF THE TOP SNOWBOARDERS FROM THE COUNTRY SET TO COMPETE. JUST TAKE A LOOK AT CITY HALL PLAZA ...

Boston Globe CEO Linda Pizzuti Henry is backing out as an investor in Boston Unity Soccer Partners — and the new pro women’s soccer team it’s vying to bring to White Stadium — amid ...

(AP Photo/John Raoux, File) Former NBA player Michael Carter-Williams is hoping to get a WNBA franchise in Boston whether it’s through expansion or being a destination for a current team that wants to ...